GL1X · GenesisL1 explorer

MolNFT v1 · #122381 · protein

Crystal structure of the prefusion glycoprotein of lcmv

5INE · Pre-glycoprotein polyprotein gp complex: “Crystal structure of the prefusion glycoprotein of lcmv”. X-ray diffraction, 3 ligands (NAG, BMA, MAN), 6 pockets (best druggability 0.84). MolNFT v1 #122381 on GenesisL1: 3D structure…

PDB
5INE
Type
protein
Length
687 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pre-glycoprotein polyprotein gp complex
UniProt
Q9ICW1
Ligands
NAG, BMA, MAN
Pockets
6 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 34% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APre-glycoprotein polyprotein gp complexprotein34835% helix, 19% strandQ9ICW1
BPre-glycoprotein polyprotein gp complexprotein33934% helix, 22% strandQ9ICW1

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 29 copies · chains A, B
  • BMA · beta-D-mannopyranose · sugar · 11 copies
  • MAN · alpha-D-mannopyranose · sugar · 5 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111830.840.8589empty
22590.690.8532NAG
32450.690.8532NAG
41900.570.8137empty
51070.560.8417empty

Interfaces

1 interface between chains.

  • A–B · 2224 Ų buried · 32 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 17 glycan, 12 disulfide (N-glycosylation, disulfide).

Compared structures

  • 5INE · Crystal structure of the prefusion glycoprotein of LCMV · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.